Halpern Samantha E, Samoylova Mariya L, Shaw Brian I, Kesseli Samuel J, Hartwig Matthew G, Patel Yuval A, McElroy Lisa M, Barbas Andrew S
School of Medicine, Duke University, Durham, NC.
Department of Surgery, Duke University Medical Center, Durham, NC.
Transplant Direct. 2021 Aug 6;7(9):e742. doi: 10.1097/TXD.0000000000001173. eCollection 2021 Sep.
Livers from "nonideal" but acceptable donors are underutilized; however, organ procurement organization (OPO) metrics do not assess how OPO-specific practices contribute to these trends. In this analysis, we evaluated nonideal liver donor avoidance or risk aversion among OPOs and within US donation service areas (DSAs).
Adult donors in the United Network for Organ Sharing registry who donated ≥1 organ for transplantation between 2007 and 2019 were included. Nonideal donors were defined by any of the following: age > 70, hepatitis C seropositive, body mass index > 40, donation after circulatory death, or history of malignancy. OPO-specific performance was evaluated based on rates of nonideal donor pursuit and consent attainment. DSA performance (OPO + transplant centers) was evaluated based on rates of nonideal donor pursuit, consent attainment, liver recovery, and transplantation. Lower rates were considered to represent increased donor avoidance or increased risk aversion.
Of 97 911 donors, 31 799 (32.5%) were nonideal. Unadjusted OPO-level rates of nonideal donor pursuit ranged from 88% to 100%. In a 5-tier system of overall risk aversion, tier 5 DSAs (least risk-averse) and tier 1 DSAs (most risk-averse) had the highest and lowest respective rates of non-ideal donor pursuit, consent attainment, liver recovery, and transplantation. On average, recovery rates were over 25% higher among tier 5 versus tier 1 DSAs. If tier 1 DSAs had achieved the same average liver recovery rate as tier 5 DSAs, approximately 2100 additional livers could have been recovered during the study period.
Most OPOs aggressively pursue nonideal liver donors; however, recovery practices vary widely among DSAs. Fair OPO evaluations should consider early donation process stages to best disentangle OPO and center-level practices.
“非理想”但可接受的供体肝脏未得到充分利用;然而,器官获取组织(OPO)的指标并未评估特定OPO的做法如何导致了这些趋势。在本分析中,我们评估了OPO之间以及美国捐赠服务区域(DSA)内对非理想肝脏供体的回避或风险规避情况。
纳入器官共享联合网络登记处2007年至2019年间捐赠≥1个器官用于移植的成年供体。非理想供体由以下任何一项定义:年龄>70岁、丙型肝炎血清学阳性、体重指数>40、循环死亡后捐赠或有恶性肿瘤病史。基于非理想供体的追求率和同意达成率评估特定OPO的表现。基于非理想供体的追求率、同意达成率、肝脏获取率和移植率评估DSA的表现(OPO+移植中心)。较低的比率被认为代表更高的供体回避或更高的风险规避。
在97911名供体中,31799名(32.5%)为非理想供体。未经调整的OPO层面非理想供体追求率在88%至100%之间。在一个5级总体风险规避系统中,5级DSA(风险规避程度最低)和1级DSA(风险规避程度最高)的非理想供体追求率、同意达成率、肝脏获取率和移植率分别最高和最低。平均而言,5级DSA的获取率比1级DSA高出25%以上。如果1级DSA的平均肝脏获取率与5级DSA相同,在研究期间大约可以多获取2100个肝脏。
大多数OPO积极争取非理想肝脏供体;然而,DSA之间的获取做法差异很大。公平的OPO评估应考虑捐赠过程的早期阶段,以最好地区分OPO和中心层面的做法。